Vivo Infusion (InTandem-backed) Acquires Infusion Center of Pennsylvania

Vivo Infusion Acquires Neurology Institute of San Antonio and Vista Infusions

January 9, 2025

Healthcare Services

Vivo Infusion has acquired the Neurology Institute of San Antonio (NISA) and Vista Infusions, expanding its ambulatory infusion and neurology services footprint in Texas. The deal brings Vivo to nearly 90 infusion centers across 15 states and increases its presence in Texas to about 20 locations; financial terms were not disclosed.

Vivo Infusion Acquires Infusion Associates from Boyne Capital

July 9, 2024

Healthcare Services

Vivo Infusion, a national provider of community-based ambulatory infusion and injection services, has acquired Infusion Associates, a Midwest-focused ambulatory infusion operator headquartered in Grand Rapids, Michigan. The deal—sold by Boyne Capital and supported by Vivo's investor InTandem Capital Partners—adds Infusion Associates' 14 locations in Michigan, Minnesota, Ohio and Wisconsin to the Vivo platform as it nears management of ~80 centers across 15 states; financial terms were not disclosed.

Vivo Infusion Acquires Specialty Infusion

June 20, 2023

Healthcare Services

Vivo Infusion, a national provider of community-based ambulatory infusion and injection care, has acquired Specialty Infusion, a provider of ambulatory infusion and specialty pharmacy services operating 14 centers across New York, Massachusetts, and New Jersey. The deal expands Vivo's footprint to a combined 55 ambulatory infusion centers across ten states; financial terms were not disclosed.

MediPharm Labs Corp. Acquires VIVO Cannabis Inc.

April 1, 2023

Pharmaceuticals

Effective April 1, 2023, MediPharm Labs Corp. completed an all-equity arrangement to acquire all outstanding shares of VIVO Cannabis Inc., making VIVO a wholly-owned subsidiary. Under the arrangement, former VIVO shareholders received 0.2910 MediPharm common shares per VIVO share and MediPharm issued approximately 107,930,964 shares as consideration; VIVO shares are expected to be delisted from the Toronto Stock Exchange.

Vivo Infusion Acquires CIVIC Infusion

January 31, 2023

Healthcare Services

Vivo Infusion, a provider of community-based ambulatory infusion services, has acquired CIVIC Infusion, which operates infusion centers in Connecticut and New York. CIVIC co-founders Drs. Barry Stein and Robert Roteman will join Vivo as Medical Directors; the combined organization now reaches 36 ambulatory infusion centers across nine states. Financial terms were not disclosed.

InTandem Capital Partners Recapitalizes MPP Infusion Centers and ID Consultants to Create Vivo Infusion

March 10, 2022

Healthcare Services

InTandem Capital Partners completed a majority recapitalization combining MPP Infusion Centers and ID Consultants Infusion Centers to form Vivo Infusion, an ambulatory infusion services platform. The combined business operates 24 locations across Texas, Colorado, Ohio, Florida, and Oklahoma and plans further market densification and geographic expansion.